Age‐related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Monika Rataj Baniowska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génétique Biologie Moléculaire et Cellulaire, IGBMC, UMR 7104- UMR-S 1258, Université de Strasbourg, CNRS, Inserm, Illkirch, France. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Disease Models, Animal, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Dementia Research Institute, Alzheimer's Research UK, Istituto Pasteur-Fondazione Cenci Bolognetti.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Down syndrome (DS) is the leading genetic cause of intellectual disability and Alzheimer's disease (AD), with over 90% of individuals developing AD‐related dementia (DSAD). The triplication of the APP gene on chromosome 21 drives early amyloid‐β (Aβ) accumulation, but other Hsa21 genes also contribute to pathology. Current DSAD models are limited by species‐specific Aβ differences. METHODS We developed and characterized two novel DSAD mouse models with partial humanization of Aβ. RESULTS These models exhibit early AD features: cognitive deficits, hyperactivity, altered novelty and risk responses, tau hyperphosphorylation, and endolysosomal dysfunction. Amyloid precursor protein (APP) processing shifts toward β‐secretase, increasing CTF‐β and altering Aβ dynamics. Aβ humanization modulates behavior, improving specific cognitive tasks but enhancing anxiety traits. Myelinosome formation and impaired autophagic flux further align these models with human AD pathology. DISCUSSION They offer valuable tools to investigate early DSAD mechanisms and therapeutic strategies, pending development of a fully humanized trisomic model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Génétique Biologie Moléculaire et Cellulaire, IGBMC, UMR 7104- UMR-S 1258, Université de Strasbourg, CNRS, Inserm, Illkirch, France.
- UK Dementia Research Institute at UCL, London, UK.
- Department of Biochemical Sciences A. Rossi Fanelli, Sapienza University of Rome, Rome, Italy.
- Université de Strasbourg, CNRS, Inserm, PHEN-Institut Clinique de la Souris, PHEN-ICS, CELPHEDIA, UAR2062, US66, Illkirch, France.
- CNRS, CELPHEDIA Core, UAR2052, Villejuif, France.
ORCID-Profile: Yann Herault
Förderung
- UK Dementia Research Institute
- Alzheimer's Research UK
- Istituto Pasteur-Fondazione Cenci Bolognetti
- Sapienza Università di Roma
- Agence Nationale de la Recherche
- European Commission
- Fondation Jérôme Lejeune
Zitieren
APA
Baniowska, M. R., Mumford, P., Prestia, F., Stephan, P., Beament, M., Birling, M. C., Lanzillotta, C., Ciafardini, L., Barone, E., Lau, G., Chevalier, C., Nahy, C., Messaddeq, N., Lestra, T., Wu, Y., Nalesso, V., Di Domenico, F., Wiseman, F., & Herault, Y. (2026). Age‐related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71498
Vancouver
Baniowska MR, Mumford P, Prestia F, Stephan P, Beament M, Birling MC, et al. Age‐related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71498
BibTeX
@article{Baniowska2026,
author = {Baniowska, Monika Rataj and Mumford, Paige and Prestia, Francesca and Stephan, Pauline and Beament, Millie and Birling, Marie-Christine and Lanzillotta, Chiara and Ciafardini, Letizia and Barone, Eugenio and Lau, Gloria and Chevalier, Claire and Nahy, Chadia and Messaddeq, Nadia and Lestra, Thais and Wu, Yixing and Nalesso, Valérie and Di Domenico, Fabio and Wiseman, Frances and Herault, Yann},
title = {Age‐related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndrome},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71498}
}
EUVIMED